SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-039817
Filing Date
2022-06-29
Accepted
2022-06-29 17:01:38
Documents
2
Period of Report
2022-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1645
2 EX-24 DOCUMENT attachment1.htm EX-24 3909
  Complete submission text file 0001209191-22-039817.txt   6904
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address
Powl Brian T. (Reporting) CIK: 0001934232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36076 | Film No.: 221055377